Shaolin Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-917,120
| Closed | -$91.6K | – | 429 |
|
|
2023
Q4 | $91.6K | Buy |
917,120
+122,788
| +15% | +$12.3K | ﹤0.01% | 172 |
|
|
2023
Q3 | $119K | Buy |
+794,332
| New | +$119K | ﹤0.01% | 248 |
|
|
2023
Q2 | – | Sell |
-729,332
| Closed | -$40K | – | 503 |
|
|
2023
Q1 | $40K | Buy |
729,332
+299,517
| +70% | +$16.4K | ﹤0.01% | 456 |
|
|
2022
Q4 | $20K | Hold |
429,815
| – | – | ﹤0.01% | 577 |
|
|
2022
Q3 | $28K | Hold |
429,815
| – | – | ﹤0.01% | 662 |
|
|
2022
Q2 | $64K | Buy |
429,815
+158,331
| +58% | +$23.6K | ﹤0.01% | 643 |
|
|
2022
Q1 | $81K | Hold |
271,484
| – | – | ﹤0.01% | 687 |
|
|
2021
Q4 | $138K | Hold |
271,484
| – | – | ﹤0.01% | 620 |
|
|
2021
Q3 | $159K | Buy |
+271,484
| New | +$159K | ﹤0.01% | 473 |
|